About
EchoGo uses ground-breaking machine learning and patented artificial intelligence to more accurately
diagnose Cardiovascular Diseases earlier in the care pathway. It enables physicians everywhere to use echocardiography – the least invasive and most accessible cardiac imaging modality –
to diagnose heart failure and coronary artery disease earlier, faster, and in more people.
Key Facts
Series B in 2021, 100 people, 5 years old
Successes in UK/NHS
£2.7M funding via the NHS AI award Implemented in 20 sites in the UKCompany details
Solutions
Providing advanced screening and diagnostics
Specialism
Specialised diagnostics
Company details

Want to connect with this innovator?
Make an enquiryWebsite
www.ultromics.comMarkets already exporting to
USA, UK
Desired Markets
Europe, Asia
Desired customer types
Hospitals, Primary Care, Health Systems